English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jun 26, 2026

Yale study identifies gut-based immunity as key to norovirus protection
+ Pharmaceuticals
Patient Daily | Jun 26, 2026

UC San Diego researchers develop new screening to identify gene expression regulators
+ Pharmaceuticals
Patient Daily | Jun 25, 2026

Study finds musculoskeletal pain in Brazilian children is recurrent and often misunderstood
+ Regulatory
A. P. Berry | Jun 25, 2026

Pharmacy benefits consultant: 'Most plan sponsors have never been shown' the generic spread their PBM charges
+ Regulatory
Patient Daily | Jun 25, 2026

Real America's Voice: 340B program envisioned for neighborhood clinics has grown into 'taxpayer-supported enterprises'
+ Pharmaceuticals
Patient Daily | Jun 25, 2026

Biopharma dealmaking grows more complex as companies pursue multiple tracks at BIO 2026
+ Pharmaceuticals
Patient Daily | Jun 25, 2026

Base editing technique enables detailed study of early human embryonic development
+ Pharmaceuticals
Patient Daily | Jun 25, 2026

Researchers report new strategy to target tumor microenvironments for cancer therapy

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation